These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 23675665)

  • 1. Rivaroxaban for thromboprophylaxis in acutely ill medical patients.
    Cohen AT; Spiro TE; Spyropoulos AC;
    N Engl J Med; 2013 May; 368(20):1945-6. PubMed ID: 23675665
    [No Abstract]   [Full Text] [Related]  

  • 2. Rivaroxaban for thromboprophylaxis in acutely ill medical patients.
    Vink R; Sohne M
    N Engl J Med; 2013 May; 368(20):1945. PubMed ID: 23675668
    [No Abstract]   [Full Text] [Related]  

  • 3. Rivaroxaban for thromboprophylaxis in acutely ill medical patients.
    Derksen RJ; Mulder WM; Mulder JW
    N Engl J Med; 2013 May; 368(20):1945. PubMed ID: 23675667
    [No Abstract]   [Full Text] [Related]  

  • 4. Rivaroxaban for thromboprophylaxis in acutely ill medical patients.
    Alameddine R; Husari A
    N Engl J Med; 2013 May; 368(20):1944-5. PubMed ID: 23675666
    [No Abstract]   [Full Text] [Related]  

  • 5. [Rivaroxaban for thromboprophylaxis inpatients with acute medical illness].
    Ruiz Muñoz M
    Rev Clin Esp (Barc); 2013; 213(5):257. PubMed ID: 23940851
    [No Abstract]   [Full Text] [Related]  

  • 6. Rivaroxaban for thromboprophylaxis.
    Lotke PA
    N Engl J Med; 2008 Nov; 359(20):2174; author reply 2175-6. PubMed ID: 19009675
    [No Abstract]   [Full Text] [Related]  

  • 7. Rivaroxaban for thromboprophylaxis in acutely ill medical patients.
    Cohen AT; Spiro TE; Büller HR; Haskell L; Hu D; Hull R; Mebazaa A; Merli G; Schellong S; Spyropoulos AC; Tapson V;
    N Engl J Med; 2013 Feb; 368(6):513-23. PubMed ID: 23388003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective factor Xa inhibition for thromboprophylaxis.
    Eikelboom JW; Weitz JI
    Lancet; 2008 Jul; 372(9632):6-8. PubMed ID: 18582929
    [No Abstract]   [Full Text] [Related]  

  • 9. Rivaroxaban for thromboprophylaxis.
    Schuman EP
    N Engl J Med; 2008 Nov; 359(20):2174; author reply 2175-6. PubMed ID: 19005203
    [No Abstract]   [Full Text] [Related]  

  • 10. Rivaroxaban for thromboprophylaxis.
    ten Cate H; Hamulyak K
    N Engl J Med; 2008 Nov; 359(20):2174-5; author reply 2176. PubMed ID: 19009676
    [No Abstract]   [Full Text] [Related]  

  • 11. Dabigatran and rivaroxaban for prevention of venous thromboembolism--systematic review and adjusted indirect comparison.
    Loke YK; Kwok CS
    J Clin Pharm Ther; 2011 Feb; 36(1):111-24. PubMed ID: 21198726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty.
    Lassen MR; Ageno W; Borris LC; Lieberman JR; Rosencher N; Bandel TJ; Misselwitz F; Turpie AG;
    N Engl J Med; 2008 Jun; 358(26):2776-86. PubMed ID: 18579812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty.
    Eriksson BI; Borris LC; Friedman RJ; Haas S; Huisman MV; Kakkar AK; Bandel TJ; Beckmann H; Muehlhofer E; Misselwitz F; Geerts W;
    N Engl J Med; 2008 Jun; 358(26):2765-75. PubMed ID: 18579811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ["Xa-tra-xa": opportunities and open questions about new anticoagulants].
    Beer JH
    Praxis (Bern 1994); 2011 Aug; 100(16):947. PubMed ID: 21910293
    [No Abstract]   [Full Text] [Related]  

  • 15. Thromboprophylaxis after minimally invasive total knee arthroplasty: a comparison of rivaroxaban and enoxaparin.
    Yen SH; Lin PC; Kuo FC; Wang JW
    Biomed J; 2014; 37(4):199-204. PubMed ID: 25116715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concomitant use of medication with antiplatelet effects in patients receiving either rivaroxaban or enoxaparin after total hip or knee arthroplasty.
    Eriksson BI; Rosencher N; Friedman RJ; Homering M; Dahl OE
    Thromb Res; 2012 Aug; 130(2):147-51. PubMed ID: 22225858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New anticoagulants--the path from discovery to clinical practice.
    Lohrmann J; Becker RC
    N Engl J Med; 2008 Jun; 358(26):2827-9. PubMed ID: 18579818
    [No Abstract]   [Full Text] [Related]  

  • 18. Oral rivaroxaban for symptomatic venous thromboembolism.
    Landman GW; Gans RO
    N Engl J Med; 2011 Mar; 364(12):1178; author reply 1178. PubMed ID: 21428778
    [No Abstract]   [Full Text] [Related]  

  • 19. New agents for orthopaedic thromboprophylaxis: caution essential, but time will tell.
    Verma AK
    ANZ J Surg; 2009 Nov; 79(11):773-4. PubMed ID: 20078521
    [No Abstract]   [Full Text] [Related]  

  • 20. An indirect comparison, via enoxaparin, of rivaroxaban with dabigatran in the prevention of venous thromboembolism after hip or knee replacement.
    Lereun C; Wells P; Diamantopoulos A; Rasul F; Lees M; Sengupta N
    J Med Econ; 2011; 14(2):238-44. PubMed ID: 21385145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.